QA: Atreca Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001532346_2023_Atreca_Inc.pdf

Logs

Graph

Absolute values for 0001532346, Atreca Inc.

  xvar xval
0 AssetsCurrent 78,026,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 37,972,000
3 remainder_Assets 39,032,000
4 LiabilitiesCurrent 16,293,000
5 LiabilitiesNoncurrent 60,331,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 31,466,000
9 ResearchAndDevelopmentExpense 66,829,000
10 remainder_Expenses 449,000
11 remainder_Revenues 770,000
12 remainder_NetIncome 817,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 155,030,000
1 Liabilities 76,624,000
2 Expenses 98,744,000
3 Revenues 770,000
4 StockholdersEquity 78,406,000
5 NetIncome -97,157,000
6 ComprehensiveNetIncome -97,157,000
7 BaseVar 165,992,500
8 EconomicCapitalRatio 0.325

Edgar->Model Mapping

Feature Distribution

Change over Time